Cycloxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation
Yen-Fu Chen, Paresh Jobanputra, Pelham Barton, Stirling Bryan, Anne Fry-Smith, Gwyn Harris, RS Taylor
Research output: Contribution to journal › Article
202Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Cycloxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation'. Together they form a unique fingerprint.